We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-3.39%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$2.6B
AUM Growth
+$272M
Cap. Flow
+$580M
Cap. Flow %
22.28%
Top 10 Hldgs %
59.11%
Holding
341
New
89
Increased
83
Reduced
62
Closed
85

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$32.4M
2
AZN icon
AstraZeneca
AZN
+$11.6M
3
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
+$10.4M
4
QRHC icon
Quest Resource Holding
QRHC
+$8.96M
5
MBOT icon
Microbot Medical
MBOT
+$7.86M

Top Sells

Rank Stock Value
1
WY icon
Weyerhaeuser
WY
+$64.6M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$53.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$16.1M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$13.3M
5
OPK icon
Opko Health
OPK
+$10.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.32%
2 Healthcare 6.56%
3 Energy 0.47%
4 Consumer Discretionary 0.36%
5 Industrials 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHV icon
101
Achieve Life Sciences
ACHV
$729M
$2.1M 0.08%
358
-61
-15% -$424K
NBIX icon
102
PUT
Neurocrine Biosciences
NBIX
$15.6B
$2.06M 0.08%
1,314
+1,214
+1,214% +$18.1K
GWPH
103
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.02M 0.08%
250
-235
-48% -$20.8K
VNDA icon
104
CALL
Vanda Pharmaceuticals
VNDA
$305M
$2M 0.08%
3,316
+1,616
+95% +$21.2K
TRUP icon
105
Trupanion
TRUP
$1.13B
$2M 0.08%
+235,000
New +$2.18M
SGEN
106
DELISTED
Seagen Inc. Common Stock
SGEN
$1.94M 0.07%
+52,047
New +$2.05M
RMTI icon
107
Rockwell Medical
RMTI
$31.4M
$1.93M 0.07%
+1,924
New +$2.17M
ACGN
108
DELISTED
Aceragen Inc
ACGN
$1.92M 0.07%
773
+206
+36% +$593K
TTOO
109
DELISTED
T2 Biosystems, Inc
TTOO
$1.91M 0.07%
+21
New +$1.95M
ABUS icon
110
CALL
Arbutus Biopharma
ABUS
$1.01B
$1.87M 0.07%
+883
New +$14.4K
PGEN icon
111
CALL
Precigen
PGEN
$2.42B
$1.86M 0.07%
+1,046
New +$21.4K
PGEN icon
112
PUT
Precigen
PGEN
$2.42B
$1.86M 0.07%
+1,046
New +$21.4K
RVNC
113
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.85M 0.07%
95,800
+28,600
+43% +$745K
RXDX
114
DELISTED
Ignyta, Inc.
RXDX
$1.85M 0.07%
229,701
+180,701
+369% +$1.45M
XOMA
115
DELISTED
Xoma
XOMA
$1.83M 0.07%
21,716
+7,586
+54% +$647K
LITS
116
Lite Strategy Inc
LITS
$37.8M
$1.82M 0.07%
13,186
-314
-2% -$42.6K
INFI
117
PUT
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.81M 0.07%
+1,351
New +$16.1K
ARNA
118
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.74M 0.07%
415
+5
+1% +$223
ADVM
119
DELISTED
Adverum Biotechnologies
ADVM
$1.71M 0.07%
+5,000
New +$1.49M
CBAY
120
DELISTED
Cymabay Therapeutics
CBAY
$1.71M 0.07%
+249,900
New +$1.54M
ALKS icon
121
Alkermes
ALKS
$7.56B
$1.7M 0.07%
+39,695
New +$1.78M
NWBO
122
PUT
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$1.69M 0.06%
3,353
+1,512
+82% +$9.29K
CLRB icon
123
Cellectar Biosciences
CLRB
$21.9M
$1.66M 0.06%
+24
New +$2.07M
RXII
124
PUT
DELISTED
GALENA BIOPHARMA INC COM
RXII
$1.61M 0.06%
7,839
+683
+10% +$141K
XNCR icon
125
Xencor
XNCR
$1.77B
$1.59M 0.06%
171,275
-38,411
-18% -$389K
3 4
5
6 7

Similar funds

IWA
Independent Wealth Advisors Cary, North Carolina $111M AUM
BFA
Ballast Financial Advisors West Chester, Pennsylvania $110M AUM
WPWM
Western Pacific Wealth Management Lake Forest, Illinois $111M AUM 26.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
ZS
Zenith Solutions Philadelphia, Pennsylvania $110M AUM
KC
Karras Company Roy, Utah $110M AUM
FI
FinArc Investments Norwood, Massachusetts $110M AUM
CIM
Catalyst Investment Management Windham, New Hampshire $110M AUM

Sabby Management's Q3 2014 Portfolio in Review

As of Q3 2014, Sabby Management held 341 positions worth $2.6B, up 12% from $2.33B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Sabby Management deployed $580M of net new capital in Q3 2014, opening 89 new positions and adding to 83 existing holdings. Its largest new stake was Acadia Healthcare: 663,324 shares worth $16.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 87% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was SALIX PHARMACEUTICALS LTD DEL, an estimated $6.87M trimmed.

  • Sabby Management's largest Q3 2014 buy was Acadia Healthcare: 663,324 shares worth $16.4M.
  • Sabby Management added most to AstraZeneca in Q3 2014, an estimated $11.6M increase.
  • Sabby Management's biggest Q3 2014 reduction was SALIX PHARMACEUTICALS LTD DEL, cutting an estimated $6.87M.
  • Sabby Management fully exited Weyerhaeuser in Q3 2014, selling an estimated $64.6M.
  • Sabby Management's ten largest holdings make up 59% of its $2.6B portfolio in Q3 2014.
  • Sabby Management opened 89 new positions and closed 85 in Q3 2014.
  • Sabby Management's portfolio value rose 12% quarter-over-quarter to $2.6B.

Based on Sabby Management's 13F filing for Q3 2014, filed 14 Nov 2014.